Classic cheap medicine is expected to usher in "new life"

First financial daily Wang Weijia April 16, 2014 Yesterday, the national health and Family Planning Commission, the national development and Reform Commission, the Ministry of industry and information technology, the Ministry of finance, the Ministry of human resources and social security, the Ministry of Commerce, the food and drug administration, the Chinese medicine bureau and other eight departments jointly held a special meeting to announce the "opinions on ensuring the supply of commonly used low-cost drugs" (hereinafter referred to as the "opinions") adopted by the leading group of medical reform of the State Council And this policy is expected to be the most effective way to solve the disappearance of classic cheap drugs in the market Before that, the shortage of drugs has become increasingly prominent, including protamine necessary for heart surgery, methimazole for hyperthyroidism treatment, ketamine for anesthesia and so on Some drugs even have the phenomenon of "one drug is hard to find", and the State Council has made comments on it for many times The reporter of the first financial daily noted that the opinions published yesterday made clear the policies and measures to ensure the production and supply of commonly used low-cost drugs, including a batch of classic old drugs, in terms of improving price management, improving purchasing methods, establishing a shortage of drug reserves, and increasing policy support "In fact, if you look closely, you will find that the core drug catalog and pricing are not published this time, because there are still differences." Yesterday, a senior person close to the policy-making level told the first financial daily The above people told the first financial daily that the national development and Reform Commission has determined 890 kinds of drugs with low price last year Due to the same selection principles of low price, safety and clinical use, a considerable number of basic drugs have been included in the list of low price drugs at the present stage "But this means that once the directory of low-cost drugs starts to operate and the online bidding procurement is carried out in accordance with the existing methods, there will be conflicts with the existing local governments in mastering the directory of basic drugs and the operation mechanism of the bidding procurement agencies, which is also a very important reason why the directory has not been published so far." These people further said On the other hand, the price is more foggy Yesterday's "opinions" made it clear for the first time that for drugs included in the list of national low-cost drugs, the maximum retail price limit for each specific variety was cancelled, allowing producers and operators to independently set or adjust the retail price according to the cost of drug production and market supply and demand, so as to ensure reasonable profits According to the standard of daily average cost, each region determines the list of low-cost drugs within the pricing range of its own province (District, city) "It has been said before that the average daily cost of Chinese patent medicine is no more than 5 yuan, and the average daily cost of chemical medicine is no more than 3 yuan Although it was not finally announced today (15th), there should be no big difference." Said the senior person to reporters At yesterday's meeting, song Dacai, head of the medicine price department of the price department of the national development and Reform Commission, who is in charge of price, explained the calculation method with an example of "daily average price of 3 yuan" "If the standard of daily average cost is controlled at 3 yuan, the conversion of the final price set by the enterprise into the daily average cost cannot exceed the upper limit of 3 yuan According to the average usage, such as twice or three times a day, the cost calculated by converting the retail price set by the enterprise into the usage, the total daily average cost of the last whole day shall not exceed 3 yuan." Song Dacai said at the meeting The impact of this approach on enterprises may be the first to emerge According to the idea already published by the national development and Reform Commission, after drugs meeting the daily average cost standard are included in the list of low-cost drugs, the specific retail price stipulated by the original state is automatically cancelled, and enterprises can adjust the price reasonably in real time according to the change of cost and the change of market supply and demand However, if the daily average cost breaks through the control standard of low-cost drugs due to the increase of cost or the change of usage and dosage, the list of low-cost drugs shall be withdrawn and the maximum retail guide price shall be set again The drug pilot countries with small dosage and short market supply shall be designated for production and unified pricing Due to the fact that the catalogue and price of the next market of directly related enterprises have not yet been published, many enterprises said in an interview yesterday that they are still cautious and optimistic about the policy at present and need to wait for more details to be published to evaluate the impact on enterprises Li Hong, assistant general manager of Guangyao group, told the first Financial Daily yesterday that the list management and dynamic adjustment were carried out for low-cost drugs Within the daily consumption expenses, the enterprises made their own pricing according to market, cost and other factors, which not only changed the "ceiling" pricing mode of the highest retail price pricing, but also greatly improved the production enthusiasm of enterprises Li Hong takes Guangyao group as an example If according to the previous market rumors that the daily consumption cost of Chinese patent medicine does not exceed 5 yuan and the daily consumption cost of chemical medicine does not exceed 3 yuan, more than 70% of the main products sold by Guangyao group belong to low-cost drugs, many of which have not been adjusted by the government for many years, resulting in nearly 50% of low-cost drugs cannot be produced Due to the rising cost of medicine and labor, the factory price of these products is almost close to the highest retail price The price of Baoji pills and other drugs under the group has not been adjusted for more than ten years, and they are almost sold at a loss If the low-cost drug list management is implemented, there will be a certain degree of autonomy in the price, and there will be a certain amount of space for independent adjustment in the price of products The production enthusiasm of enterprises will be greatly improved, and some low-cost drug markets will be restored Yesterday, the eight departments did not give a clear timetable for the highly concerned catalogue and price of low-cost drugs, but the national development and Reform Commission said at the meeting that there would be no big suspense about the introduction of the drug within the year and that "the sooner the better".